Probiotics can reduce COVID symptoms and delay disease, study finds
In a new study, a group of researchers from Duke Health examined whether probiotics, specifically a type called lactobacillus, help fight against COVID-19.
They decided...
Aerobic exercise is key to reducing hospitalizations
A study conducted at the University of Gothenburg has uncovered a promising link between aerobic fitness and reduced hospitalizations.
This research, published in the European...
Common vitamin B3 supplement may increase cancer risk
A recent study from the University of Missouri has raised concerns about the safety of high doses of nicotinamide riboside (NR), a form of...
Better blood pressure control means lower dementia risk
Researchers from Beijing Anzhen Hospital and other institutions have conducted a study that brings new insights into how managing blood pressure can significantly impact...
“Night owls” at higher risk of this artery disease, study shows
A study from the University of Gothenburg, Sweden, published in the journal Sleep Medicine, reveals a striking link between circadian rhythm, or sleep-wake patterns,...
New hope in Alzheimer’s treatment
Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in Alzheimer’s disease research.
Their study, published in...
New drug can block artery fat, improve heart health
In a significant stride forward in cardiovascular research, scientists at the University of Aberdeen have reported promising results in the fight against heart disease...
Microbiome changes linked to kidney stones, study finds
A groundbreaking study from the Lawson Health Research Institute and Western University, published in the journal Microbiome, has revealed a big connection between changes...
Light, sound, and magnets provide new hope for Alzheimer’s treatment
Researchers are exploring exciting new ways to treat Alzheimer's disease, a condition where the brain loses its ability to function properly.
A recent review in...
Keeping an eye on JN.1: The new COVID variant of interest
The World Health Organization (WHO) recently designated a new COVID-19 variant, JN.1, as a "variant of interest."
This classification means that health officials worldwide are...